DOI: 10.1128/AAC.01302-18
Article Information
PubMed
Published By
History
- Received June 18, 2018
- Returned for modification July 3, 2018
- Accepted September 6, 2018
- Published online November 26, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (September 17, 2018).
- You are viewing the most recent version of this article.
Author Information
- Xia-Fei Weia,b,
- Chun-Yang Gana,
- Jing Cuia,
- Ying-Ying Luoa,
- Xue-Fei Caia,
- Yi Yuana,
- Jing Shena,
- Zhi-Ying Lia,
- Wen-Lu Zhanga,
- Quan-Xin Longa,
- Yuan Hua,
- Juan Chena,
- Ni Tanga,
- Haitao Guoc,
- Ai-Long Huanga,b and
- Jie-Li Hua,b
- aKey Laboratory of Molecular Biology on Infectious Diseases of the Ministry of Education, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
- bCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (CCID), Hangzhou, China
- cDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Address correspondence to Ai-Long Huang, ahuang1964{at}163.com, or Jie-Li Hu, hujieli1977{at}163.com.
X.-F.W., C.-Y.G., and J.C. contributed equally to this work.
Citation Wei X-F, Gan C-Y, Cui J, Luo Y-Y, Cai X-F, Yuan Y, Shen J, Li Z-Y, Zhang W-L, Long Q-X, Hu Y, Chen J, Tang N, Guo H, Huang A-L, Hu J-L. 2018. Identification of compounds targeting hepatitis B virus core protein dimerization through a split luciferase complementation assay. Antimicrob Agents Chemother 62:e01302-18. https://doi.org/10.1128/AAC.01302-18.
